Physician profile
Codey A Tyda
NPI 1467015271
$631.10
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $325 · 2023: $156 · 2024: $20.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $164.19 | 2021-2022 | |
| Argenx US, INC. | $93.15 | 2022-2023 | Vyvgart |
| Astrazeneca Pharmaceuticals Lp | $84.51 | 2022 | |
| Abbvie INC. | $63.80 | 2022-2023 | Botox |
| Ucb, INC. | $46.23 | 2022-2023 | Briviact |
| Avanir Pharmaceuticals, INC. | $44.76 | 2021-2022 | |
| Abbott Laboratories | $29.28 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $25.83 | 2023 | Nuedexta |
| Sk Life Science, INC. | $23.46 | 2023 | Xcopri |
| Xeris Pharmaceuticals, INC. | $20.80 | 2023 | Keveyis |
| Bayer Healthcare Pharmaceuticals INC. | $20.55 | 2024 | |
| Novartis Pharmaceuticals Corporation | $14.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Codey Tyda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.